Serial Number | 90031603 |
Word Mark | WUXIDAR4 |
Filing Date | Wednesday, July 1, 2020 |
Status | 700 - REGISTERED |
Status Date | Tuesday, October 5, 2021 |
Registration Number | 6512549 |
Registration Date | Tuesday, October 5, 2021 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, January 19, 2021 |
Goods and Services | pharmaceutical preparations for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; drugs for medical purposes, namely, anticancer drugs; biological preparations for medical purposes for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; medicines for human purposes for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; Biochemical medicines for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; Antibody drug for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; multispecific antibody for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; multispecific antibody format for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; medicines for veterinary purposes for treatment of canine disease; biological preparations for veterinary purposes for treatment of canine disease |
Pseudo Mark | WUXIDAR FOUR |
Goods and Services | Product development for others; pharmaceutical drug development services; scientific research and development; pharmaceutical research; research and development of new products; Consulting services in the field of pharmaceutical technology development; Biochemical research and analysis; Biomedical research services; development of pharmaceutical preparations and medicines; Research and development of antibodies |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, July 29, 2020 |
Primary Code | 005 |
First Use Anywhere Date | Friday, September 25, 2020 |
First Use In Commerce Date | Friday, September 25, 2020 |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, July 29, 2020 |
Primary Code | 042 |
First Use Anywhere Date | Friday, September 25, 2020 |
First Use In Commerce Date | Friday, September 25, 2020 |
Party Name | WUXI XDC SINGAPORE PRIVATE LIMITED |
Party Type | 31 - New Owner After Registration |
Legal Entity Type | 24 - NOT AVAILABLE |
Address | 100 AM SINGAPORE 079027 SG |
Party Name | WuXi Biologics Co., Ltd. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 99 - Other |
Address | Wuxi, Jiangsu 204092 CN |
Party Name | WuXi Biologics Co., Ltd. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | Wuxi, Jiangsu 204092 CN |
Party Name | WuXi Biologics Co., Ltd. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Wuxi, Jiangsu 204092 CN |
Event Date | Event Description |
Wednesday, April 5, 2023 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Tuesday, October 5, 2021 | REGISTERED-PRINCIPAL REGISTER |
Wednesday, September 1, 2021 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
Tuesday, August 31, 2021 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
Friday, August 27, 2021 | STATEMENT OF USE PROCESSING COMPLETE |
Tuesday, August 24, 2021 | USE AMENDMENT FILED |
Thursday, August 26, 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Tuesday, August 24, 2021 | TEAS STATEMENT OF USE RECEIVED |
Tuesday, March 16, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, January 19, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, January 19, 2021 | PUBLISHED FOR OPPOSITION |
Wednesday, December 30, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Friday, December 11, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, December 9, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, December 8, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, December 8, 2020 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Saturday, November 28, 2020 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Saturday, November 28, 2020 | FINAL REFUSAL E-MAILED |
Saturday, November 28, 2020 | FINAL REFUSAL WRITTEN |
Wednesday, October 21, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, October 20, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, October 20, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, September 25, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, September 25, 2020 | NON-FINAL ACTION E-MAILED |
Friday, September 25, 2020 | NON-FINAL ACTION WRITTEN |
Sunday, September 13, 2020 | ASSIGNED TO EXAMINER |
Wednesday, July 29, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Saturday, July 4, 2020 | NEW APPLICATION ENTERED |